资源描述:
《重型肝炎继发医院感染的临床分析》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、重型肝炎继发医院感染的临床分析[摘要]目的探究与分析重型肝炎继发医院感染的情况。方法整群选取该院自2012年11月一2014年11月间收治的重型肝炎患者162例,对这些患者有无继发感染、感染部位等进行分析对比。结果在选取的162例重型肝炎患者中,继发医院感染者共57例,占35.2%,未继发医院感染者105例,占64.8%。在继发感染者中,腹腔感染最突出,有28例,占17.3%。其他感染依次为胆道感染14例,占8.6%,呼吸道感染9例,占5.6%,血液感染4例,占2.5%,其他感染3例,占1.9%。其中,1例患者合并2种感染。对病原菌进行检测,结果显示:共检出病原菌36株,各类病原菌中,革兰
2、阴性菌居多,共19株,占52.3%,革兰阳性菌共11株,占30.6%,真菌共6株,占16.7%o各种病原菌中,大肠杆菌数量最多,共9株,占25.0%,其他数量较多的病原菌依次为肺炎克雷伯菌7株,占19.4%;金黄色葡萄球菌5株,占13.9%;白色念珠菌4株,占11.1%;溶血性链球菌3株,占&3%。结论重型肝炎易于继发医院感染,感染的病原菌种类较多,口引起的病情较巫,预后较差,有必要较早采取防治措。[关键词]重型肝炎;医院感染;预后[中图分类号]R725[文献标识码]A[文章编号]1674-0742(2015)05(a)-0099-03FulminantHepatitisSecondary
3、ClinicalAnalysisofNosocomialInfectionZHOUYanShanghaichongminginfectiousdiseasehospitaLShanghai202150China[Abstract]ObjectiveToprobeintoandanalysisofsecondaryhospitalinfectionofseverehepatitis・MethodsTochooseselfcourtyardfromNovember2012toNovember2012were162casesofpatientswithseverehepatitis,withor
4、withoutsecondaryinfection,infectioninpatientswiththesepartsandotheranalysiscomparison.Results162casesoffulminanthepatitisinselectedpatients,secondaryhospitalinfection,atotalof57cases(35.2%),secondaryhospitalinfectionin105cases,accountingfor64.8%.Inthesecondaryinfection,abdominalcavityinfection,the
5、mostprominenthave28cases,accountingfor17.3%.Other14casesofinfectionofbi1iarytractinfection(8.6%),respiratoryinfection,9cases(5.6%),bloodstreaminfection,4cases(2.5%),other3casesofinfection,accountingfor1.9%.Amongthem,1caseofpatientswithcombinedtwokindsofinfection.Totestthepathogen,theresultsshowed:
6、atotalof36strainspathogenicbacteriadetectionofvariouskindsofpathogens,themajorityofgram-negativebacteria,atotalof19strains(52・3%),grampositivebacteria,atotalof11strains,accountingfor30.6%,fungi,atotalof6strains,accountingfor16.7%.Themostnumberofvariouskindsofpathogenicbacteria,escherichiacoli,atot
7、alof9strains,accountingfor25.0%,otherlargenumberofpathogenicbacteriaofpneumoniaklebsiellabacteriastrains,accountingfor19.4%;Staphylococcusaureus,5strains(13.9%),Candidaalbicans4strains(11.1%),Hemolyticstreptococc